Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.

Talaporfin
Подписчиков: 0, рейтинг: 0
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
IV |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C38H41N5O9 |
Molar mass | 711.772 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Talaporfin (INN, also known as aspartyl chlorin, mono-L-aspartyl chlorin e6, NPe6, or LS11) is a chlorin based photosensitizer used in photodynamic therapy (PDT).
It absorbs red light at 664-667 nm normally provided by a laser tuned to this wavelength.
It was approved in Japan (in 2004) for PDT of lung cancer and marketed as Laserphyrin.
Extracorporeal Photo-Immunotherapy for Circulating Tumor Cells